Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and aproduct launch will occur as soon as final pricing approval isreceived in July, Comline said.			

Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and

Konica lands generic x-ray contrast agent